Belgium
KiOmed Pharma is a Belgium-based biotech company founded in 2012 that focuses on developing a unique pipeline of medical devices in the fields of OsteoArthritis, skin aging, and ophthalmology. The company capitalizes on a history of innovation and expertise in exclusive natural chitosan chemistry to address unmet medical needs in high impact pathologies and major social burdens.
The company, a spinout from KitoZyme, has a strong focus on leveraging its expertise in pharmaceuticals to provide solutions for conditions like OsteoArthritis, skin aging, and ophthalmology. With its headquarters in Belgium, KiOmed Pharma has positioned itself as a key player in the pharmaceutical industry with a unique offering in the medical devices space.
Despite its significant potential, KiOmed Pharma's last investment details, including the amount and investors, are currently unavailable. However, with its strong focus on innovative solutions for prevalent medical conditions, KiOmed Pharma stands as a promising player in the biotech industry with the potential to attract significant investor interest in the future.
